EIF5A2 and non-small cell lung carcinoma: By western blot assay, increased eIF5A2 expression was observed in NSCLC cell lines (A549, H23, Calu-3, H1299, and H460 cells) as compared with the benign human bronchial epithelial HBE cell line, and EIF5A2 silencing can inhibit the cell’s motility and growth ability of H1299 and H460 cells [90].